FNFDCM
GILD icon

Folger Nolan Fleming Douglas Capital Management’s Gilead Sciences GILD Stock Holding History

Folger Nolan Fleming Douglas Capital Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		– Sell
-280
Closed -$14K – 168
2013
Q2 		$14K Buy
+280
New +$14.6K ﹤0.01% 155

Other funds holding GILD

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Folger Nolan Fleming Douglas Capital Management's GILD Position: Q3 2013 in Review

Folger Nolan Fleming Douglas Capital Management sold out of Gilead Sciences (GILD) in Q3 2013, closing a stake of 280 shares — an estimated $14K sold.

Folger Nolan Fleming Douglas Capital Management first reported a position in GILD in Q2 2013 and held it in 1 quarter. The position peaked at $14K in Q2 2013. 982 funds tracked by Wall St. Rank hold GILD as of Q3 2013.

  • Folger Nolan Fleming Douglas Capital Management reported no remaining Gilead Sciences position as of Q3 2013 after selling out during the quarter.
  • Folger Nolan Fleming Douglas Capital Management sold 280 Gilead Sciences shares in Q3 2013, an estimated $14K.
  • Folger Nolan Fleming Douglas Capital Management first reported a position in Gilead Sciences in Q2 2013 and held it in 1 quarter.
  • Folger Nolan Fleming Douglas Capital Management's Gilead Sciences position peaked at $14K in Q2 2013.
  • 982 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2013.

Based on Folger Nolan Fleming Douglas Capital Management's 13F filing for Q3 2013, filed 14 Nov 2013.